11.85
Immix Biopharma Inc (IMMX) 最新ニュース
Price to book forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Immix Biopharma, Inc. Financial Disclosures & SEC Filings - TradingView
Wall Street analysts think Immix Biopharma (IMMX) could surge 113.58%: Read this before placing a bet - MSN
IMMX News | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
Wall Street analysts see a 120.59% upside in Immix Biopharma (IMMX): Can the stock really move this high? - MSN
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Index - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2500 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000E Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc. Actuals & Estimates (NASDAQ:IMMX) - TradingView
IMMX Forecast — Price Target — Prediction for 2027 - TradingView
Immix Biopharma Inc (IMMX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Immix Biopharma analyst bullish but flags safety, adoption questions - MSN
All you need to know about Immix Biopharma (IMMX) rating upgrade to buy - MSN
All You Need to Know About Immix Biopharma (IMMX) Rating Upgrade to Buy - Yahoo Finance
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to S&P Biotechnology Select Industry Index - marketscreener.com
Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions - Benzinga
BofA initiates Immix Biopharma stock with buy rating on AL amyloidosis drug - Investing.com UK
Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet - Yahoo Finance
Immix Biopharma, Inc. Stock 12‑Month Price Target Raised to $19.79, Implies 117% Upside - TradingView
IMMX Initiates Coverage by B of A Securities -- Rating Set to Bu - GuruFocus
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
BofA Securities Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $27 - Moomoo
Immix Biopharma Inc (IMMX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immix Biopharma Inc (IMMX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immix Biopharma Inc (IMMX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IMMX Initiates Coverage On LifeSci Capital -- Rating at Outperfo - GuruFocus
Immix Biopharma Inc (IMMX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Immix Biopharma Inc (IMMX) Institutional Confidence - TradingKey
Immix Biopharma Inc (IMMX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Immix Biopharma Inc (IMMX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immix Biopharma Inc (IMMX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Immix Biopharma Initiated at Outperform by LifeSci Capital - Moomoo
IMMX Q1 2026 Earnings: EPS Beat Reflects Cost Discipline Amid Pre-Revenue Biotech Pipeline ProgressProfit Guidance Range - newsline.com
IMMX Q1 2026 Earnings: Biotech Reports Narrower-than-Expected Loss, Shares GainEPS Estimate Trend - newsline.com
Immix Biopharma Surges 5.3% as Biotech Sentiment Lifts IMMXProfit Surge Picks - newsline.com
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
What's going on with Immix Biopharma stock Thursday? - MSN
Janus Henderson files 13G/A: 9.09M shares of Immix Biopharma (IMMX) - Stock Titan
These 10 small-cap U.S. healthcare companies carry the market's most expensive valuations - Seeking Alpha
IMMX Technical Analysis | Trend, Signals & Chart Patterns | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
Immix Biopharma, Inc. Files Form 8-K Announcing Election of Directors and Corporate Details (May 2026) - Minichart
Immix Biopharma Shareholders Back Board and Auditor at AGM - TipRanks
Immix Biopharma (NASDAQ: IMMX) posts 2026 annual shareholder voting outcomes - Stock Titan
Immix Biopharma (IMMX) awards RSUs and stock options to director Helen Adams - Stock Titan
Immix Biopharma (IMMX) director Carey Ng awarded RSUs, 12,500-share option - Stock Titan
Immix Biopharma (NASDAQ: IMMX) grants RSUs and stock options to director - Stock Titan
Immix Biopharma (IMMX) CFO, President awarded 500,000 stock options at $8.78 - Stock Titan
Immix Biopharma (IMMX) director receives 6,250 RSUs and 12,500 options - Stock Titan
Immix Biopharma (IMMX) awards CEO 500,000 stock options at $8.78 strike - Stock Titan
Immix Biopharma (IMMX) director awarded RSUs and stock options in new grants - Stock Titan
Immix Biopharma (IMMX) board member receives new RSU and stock option awards - Stock Titan
Immix Biopharma (IMMX) director Jane Buchan awarded RSUs and 12,500 stock options - Stock Titan
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Ng Carey - Moomoo
Immix Biopharma Q1 2026 Earnings: Narrower-than-Expected Loss Drives Modest Stock UptickQuarterly Profit Report - newsline.com
大文字化:
|
ボリューム (24 時間):